Seeing Is Believing
Currently out of the existing stock ratings of Daniel Brennan, 16 are a HOLD (57.14%), 9 are a BUY (32.14%), 3 are a SELL (10.71%).
Analyst Daniel Brennan, currently employed at TD COWEN, carries an average stock price target met ratio of 65.37% that have a potential upside of 17.22% achieved within 149 days.
Daniel Brennan’s has documented 225 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on BRKR, Bruker at 06-Nov-2024.
Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for ILMN (ILLUMINA) at 9/22/2020. The price target of $285 was fulfilled within 2 days with a profit of $16.49 (6.14%) receiving and performance score of 30.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$66
$9.12 (16.03%)
$102
1 months 10 days ago
(10-Dec-2024)
1/3 (33.33%)
$4.85 (7.93%)
76
Sell
$60
$3.12 (5.49%)
$60
1 months 15 days ago
(05-Dec-2024)
5/5 (100%)
$0.05 (0.08%)
164
Hold
$70
$13.12 (23.07%)
$80
2 months 14 days ago
(06-Nov-2024)
4/5 (80%)
$11.08 (18.81%)
52
Buy
$75
$18.12 (31.86%)
$85
2 months 14 days ago
(06-Nov-2024)
4/6 (66.67%)
$16.08 (27.29%)
430
Hold
$77
$20.12 (35.37%)
$81
8 months ago
(20-May-2024)
7/7 (100%)
$0.53 (0.69%)
145
Which stock is Daniel Brennan is most bullish on?
What Year was the first public recommendation made by Daniel Brennan?